1. Home
  2. ESPR vs DAKT Comparison

ESPR vs DAKT Comparison

Compare ESPR & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.29

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$26.58

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
DAKT
Founded
2008
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
793.7M
872.1M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
ESPR
DAKT
Price
$3.29
$26.58
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.20
N/A
AVG Volume (30 Days)
2.9M
619.6K
Earning Date
04-02-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
86.21
N/A
EPS
N/A
0.68
Revenue
$332,314,000.00
$608,932,000.00
Revenue This Year
$27.35
$13.76
Revenue Next Year
N/A
$7.35
P/E Ratio
N/A
$37.72
Revenue Growth
185.66
6.89
52 Week Low
$0.73
$10.25
52 Week High
$4.18
$28.27

Technical Indicators

Market Signals
Indicator
ESPR
DAKT
Relative Strength Index (RSI) 43.62 61.40
Support Level $3.16 $17.70
Resistance Level $3.41 N/A
Average True Range (ATR) 0.14 1.19
MACD -0.01 -0.26
Stochastic Oscillator 5.75 47.13

Price Performance

Historical Comparison
ESPR
DAKT

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: